Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(12 sites)
United States
University of Southern California, Los Angeles, California Saint John Cancer Institute, Santa Monica, California Georgia Cancer Center (Augusta University), Augusta, Georgia Ochsner Health, New Orleans, Louisiana Atlantic Health (Overlook Medical Center), Summit, New Jersey Northwell Health, New York, New York Wake Forest University Health Sciences, Winston-Salem, North Carolina Cleveland Clinic, Cleveland, Ohio Baylor Scott & White Health, Dallas, Texas University of Texas Southwestern Medical Center, Dallas, Texas University of Washington Medical Center, Seattle, Washington University of Wisconsin Hospital and Clinic, Madison, Wisconsin